Clik here to view.
Teleflex shares slump over 10% despite posting Street-beating Q3 EPS
Shares in Teleflex (NYSE:TFX) fell today despite the medical device maker meeting earnings per share expectations on Wall Street in its 3rd quarter. The Wayne, Penn.-based company posted profits of...
View ArticleClik here to view.
Varian Q4 release sees shares slump amid new deal with McKesson, CFO retiring
Varian Medical (NYSE:VAR) today saw shares slump after releasing mostly positive Q4 earnings, while also announcing it inked a new deal with McKesson Specialty Health as well as the retirement of its...
View ArticleClik here to view.
Stryker shares strong on street-beating Q3
Shares in Stryker (NYSE:SYK) stayed steady today after the medical device maker met expectations on Wall Street with its 3rd quarter results. The Kalamazoo, Mich.-based company posted profits of $355...
View ArticleClik here to view.
Study uses nasal tissue to repair damaged knees
(Reuters) – Doctors might one day be able to harvest cells from patients’ noses to produce cartilage that can be transplanted into damaged knee joints, a small experiment suggests. Researchers tested a...
View ArticleClik here to view.
Integer Holdings Q3 EPS beats the street
Shares in Integer Holdings (NYSE:INTGR) fell slightly today after the medical device maker topped earnings per share expectations and missed slightly on revenue for its 3rd quarter. The Frisco,...
View ArticleClik here to view.
Comparing drug and medical device clinical trials
Understanding the similarities and appreciating the differences of drug and medical device clinical trials is important. A well-organized, controlled clinical trial can save time and money....
View ArticleClik here to view.
Corindus wins FDA nod for 2nd-gen CorPath GRX vascular robot-assisted surgery...
Corindus Vascular Robotics (OTC:CVRS) said yesterday that it won 510(k) clearance from the FDA for the CorPath GRX, it’s 2nd-generation vascular robot-assisted surgery platform, and plans to have it on...
View ArticleClik here to view.
Monaghan Medical touts Aerobika study
Monaghan Medical yesterday touted data from a 6-month retrospective study showing that its Aerobika device reduced drug use for treatment of chronic obstructive pulmonary device. The Syracuse,...
View ArticleClik here to view.
Litmus Health looks to bring wearables to drug development
Litmus Health said yesterday that it launched its clinical data science platform into public beta. The company hopes to use big data from wearables and connected devices to help inform endpoints for...
View ArticleClik here to view.
St. Jude Medical shareholders grudgingly approve executive tax breaks ahead...
Shareholders in St. Jude Medical (NYSE:STJ), who this week voted to approve its pending, $25 billion merger with Abbott (NYSE:ABT), grudgingly approved a measure to give tax breaks to its senior...
View ArticleClik here to view.
Senseonics submits FDA PMA application for Eversense CGM
Senseonics (NYSE:SENS) said today it submitted a premarket approval application to the FDA for its Eversense continuous glucose monitoring system. The Eversense system includes an implanted glucose...
View ArticleClik here to view.
From Zero to Six Million – Using a Component Management Process to Scale Up...
Drug delivery devices constitute one of the most rapidly growing segments of the medical device manufacturing market. Makers focus substantial R&D efforts on designing delivery mechanisms for new...
View ArticleClik here to view.
Anika’s pipeline & clinical data create steady growth in Q3
Shares in Anika Therapeutics (NSDQ:ANIK) rose yesterday after the company met expectations on Wall Street with its 3rd-quarter results. The Bedford, Mass.-based company posted profits of $8.9 million,...
View ArticleClik here to view.
OCTANe launches business growth services
Aliso Viejo, Calif.-based medtech business accelerator OCTANe said yesterday it launched OCTANe Growth Services, a new business accelerator program that aims to aid its members and partners in growing...
View ArticleClik here to view.
FDA OKs stem cell, gene therapy trial for ALS
The FDA approved a combination stem cell-gene therapy clinical trial to test the treatment’s ability to slow the progression of amyotrophic lateral sclerosis. It’s the 1st clinical trial to use neural...
View ArticleClik here to view.
Novo Nordisk shares dive after long-term growth cut
(Reuters) — Top insulin maker Novo Nordisk (NYSE:NVO) slashed its long-term profit growth forecast today, signaling no let-up in its struggles to crack the U.S. market to which its chief executive...
View ArticleClik here to view.
St. Jude calls global stop to Nanostim implants over battery issues
St. Jude Medical (NYSE:STJ) said today it is pausing the implantation of its Nanostim leadless pacemaker due to reports of battery related problems with electronic data reporting. The Little Canada,...
View ArticleClik here to view.
St. Jude wins FDA nod for Amplatzer PFO occluder
St. Jude Medical (NYSE:STJ) today won FDA approval for its Amplatzer patent foramen ovale occluder device, designed to reduce the risk of stroke in patients who’ve experienced a PFO-related stroke....
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for October 28, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
AliveCor adds weight, activity monitoring to Kardia app
AliveCor today said that its Kardia Mobile health monitoring app will now integrate weight and physical activity readings, lifting the number of vital stats the application monitors to 5. The...
View Article
